Randomised, Double-blinded, Open Label Study in Pregnant Women, Exploring the Impact of Acellular Pertussis Vaccination in Pregnancy on the Immunogenicity in Infants Randomized to Receive Either an Acellular (aP) or Whole Cell Pertussis (wP) Vaccine Subsequently
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2019
Price : $35 *
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Diphtheria tetanus and pertussis vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Acronyms GaPs
- 08 Mar 2019 Planned primary completion date changed from 1 Dec 2021 to 1 Oct 2021.
- 08 Mar 2019 Status changed from not yet recruiting to recruiting.
- 15 Jan 2019 Planned End Date changed from 1 Sep 2022 to 1 Dec 2022.